Skip to main content
. 2023 Jan 18;13:1011. doi: 10.1038/s41598-023-28135-9

Table 1.

Characteristics of participants.

n 5364
n (US) 2400
n (nordic) 835
n (Asia) 1775
n (Australia) 354
Age, yearsa 62 (47, 75)
Male (%) 2456 (45.8)
BMI, kg/m2a 24.7 (19.3, 33.4)
Never smokers, n (%)a 1327 (24.7)
Former smokers, n (%)a 1518 (28.3)
Current smokers, n (%)a 2519 (47.0)
KTR, nmol/µmol 22.6 (16.4, 34.5)
Neopterin, nmol/L 11.0 (5.14, 23.6)
CRP, mg/L 1.77 (0.24, 13.2)
Tryptophan, µmol/L 66.5 (46.2, 90.7)
Kynurenine, µmol/L 1.51 (1.05, 2.22)
KA, nmol/L 43.9 (22.0, 91.2)
AA, nmol/L 13.9 (7.99, 29.1)
HK, nmol/L 36.6 (20.3, 70.6)
XA, nmol/L 12.4 (4.6, 29.1)
HAA, nmol/L 32.6 (16.1, 59.5)
QA, nmol/L 353 (208, 685)
Creatinine, µmol/L 74.5 (52, 105)
Cotinine, nmol/L 14.4 (1, 1870)
Riboflavin, nmol/L 19.2 (5.85, 89.6)
PLP, nmol/L 37.1 (13.8, 196)

Values are median (95% CI) or n (%). AA: anthranilic acid; BMI: body mass index; CRP: C-reactive protein; HAA: 3-hydroxyanthranilic acid; HK: 3-hydroxykynurenine; KA: kynurenic acid; KTR: kynurenine/tryptophan; PLP: pyridoxal 5′-phosphate; QA: quinolinic acid; XA: xanthurenic acid.

aAge, BMI and self-reported smoking status at date of blood draw.